Latest Posts
Understanding IBD: What Everyone Should Know About Crohn’s and UC
Living with IBD means facing daily uncertainty, but understanding the differences between Crohn’s disease and ulcerative colitis can help you better advocate for yourself. We break down what these conditions mean for your daily life and long-term health journey.
New At-Home Treatment for Ulcerative Colitis Gets FDA Approval
The FDA has approved Tremfya as the first fully at-home treatment option for moderate to severe ulcerative colitis. This breakthrough allows patients to start therapy with simple injections at home instead of spending hours in infusion centers.
Teen Athlete’s Crohn’s Journey Shows IBD Won’t Stop Our Dreams
High school football player Jamal Brown’s journey with Crohn’s disease shows how IBD doesn’t have to limit our dreams. His story offers hope and practical insights for anyone in the IBD community pursuing their passions despite health challenges.
When Your Battle Is Invisible: Understanding Life With IBD
Living with IBD means fighting a daily battle that often remains invisible to others. A recent article sheds light on the unique challenges of inflammatory bowel disease and why greater awareness matters for our community.
Breakthrough Crohn’s Treatment Targets Pain AND Scar Tissue
Palisade Bio has launched a groundbreaking clinical trial for PALI-2108, the first treatment designed to target both inflammation AND scar tissue in Crohn’s disease. This dual approach could revolutionize care for patients dealing with stricturing complications.
CHOP Research Reveals New Target for Crohn’s Treatment
Researchers at Children’s Hospital of Philadelphia have identified unique pro-inflammatory epithelial cells in pediatric Crohn’s patients, offering new hope for more targeted treatments. This cellular-level discovery could lead to therapies that address specific inflammatory pathways rather than suppressing the entire immune system.
